YOLFTbeta
30

Xiangxue Pharmaceutical

300147 · SHE · Healthcare / Biotechnology

6.10CNY-0.21 (-3.33%)

Price History

Full chart

Market Stats

Previous Close6.31
Open6.12
Day Range6.05 – 6.52
52-Week Range5.03 – 11.37
Volume23.68M
Market Cap3.90B
P/E (TTM)0.00
Forward P/E59.88
EPS-2.17
Dividend Yield0.00%
Beta0.54
50-Day Avg6.65
200-Day Avg8.81

About

Xiangxue Pharmaceutical Co.,Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, diet sarsae, juice soda, soymilk, coconut juice, and fruit enzyme; and antiviral oral liquids under the Xiangxue brand name. It also provides medical devices, which includes disposable stereoscopic fixation system for brain; medical orthopedic and cosmetic adhesives; medical tumor serosa sealing adhesives; medical anastomotic adhesives; medical aural and encephalic adhesives; medical obturation adhesives; medical adhesives; and endoscopic trocar. The company was founded in 1986 and is based in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Yonghui Wang
  • Employees2.66K
  • HeadquartersNo. 2 Jinfengyuan Road, Guangzhou, China, 510663, China
  • Websitehttps://www.xphcn.com

Leadership

  • Mr. Yonghui WangChairman & GM · b. 1962
  • Mr. Feng LuFinancial Director · b. 1973
  • Mr. Lun ZengVice President · b. 1969
  • Mr. Guanghua TanGeneral Manager of Marketing Center · b. 1978
  • Ms. Zhiying KangGM of Technology R&D · b. 1977
  • Mr. Junliang ZhongGeneral Manager of Supply Chain · b. 1972
  • Runxi LiuAccounting Supervisor

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue258.31M294.81M378.63M513.38M616.09M801.02M1.26B1.52B1.46B1.86B2.19B2.50B2.79B3.07B2.97B2.19B2.30B1.86B1.60B
Growth (%)-+14.13%+28.43%+35.59%+20.01%+30.02%+57.44%+20.84%-3.90%+27.14%+17.47%+14.49%+11.26%+10.26%-3.30%-26.38%+5.13%-19.16%-14.16%
Cost of Revenue136.59M141.75M184.40M271.37M327.17M423.90M749.09M894.28M841.10M1.28B1.55B1.59B1.91B2.09B2.23B1.65B1.56B1.45B1.16B
Gross Profit121.71M153.06M194.23M242.02M288.92M377.12M512.02M629.70M623.50M585.11M632.42M910.81M880.08M979.12M741.40M533.38M743.33M407.61M435.94M
Gross Margin47.12%51.92%51.30%47.14%46.90%47.08%40.60%41.32%42.57%31.42%28.91%36.37%31.59%31.87%24.96%24.39%32.33%21.93%27.32%
Operating Expense85.93M117.74M122.84M140.67M191.73M229.95M281.74M422.76M437.94M525.16M526.88M784.79M767.51M749.87M1.33B997.52M1.08B1.19B512.54M
Operating Income35.78M35.32M71.39M101.35M97.19M147.17M230.28M206.94M185.56M59.95M105.55M126.03M112.57M229.25M-588.71M-464.14M-332.72M-784.52M-76.60M
Operating Margin13.85%11.98%18.85%19.74%15.78%18.37%18.26%13.58%12.67%3.22%4.83%5.03%4.04%7.46%-19.82%-21.22%-14.47%-42.21%-4.80%
EBITDA51.98M62.22M86.19M122.21M143.87M180.95M272.43M325.28M299.43M210.20M157.29M370.33M304.93M447.17M125.02M60.29M282.20M-15.70M-858.30M
EBITDA Margin20.12%21.11%22.76%23.81%23.35%22.59%21.60%21.34%20.44%11.29%7.19%14.79%10.94%14.56%4.21%2.76%12.27%-0.84%-53.80%
Net Income30.78M35.95M50.92M74.20M83.50M107.17M158.24M196.80M177.30M66.02M65.94M56.44M76.51M98.42M-688.47M-530.06M-388.96M-858.56M-1.39B
Net Income Margin11.92%12.19%13.45%14.45%13.55%13.38%12.55%12.91%12.11%3.55%3.01%2.25%2.75%3.20%-23.18%-24.24%-16.92%-46.19%-87.26%
R&D7.83M9.70M12.39M15.51M19.71M25.66M31.60M50.76M45.60M33.29M40.05M38.67M61.27M66.99M90.60M94.79M89.76M92.29M70.95M
R&D as % of Total Revenue3.03%3.29%3.27%3.02%3.20%3.20%2.51%3.33%3.11%1.79%1.83%1.54%2.20%2.18%3.05%4.33%3.90%4.97%4.45%
Interest Expense1.78M6.15M11.30M15.75M18.62M38.98M70.55M70.97M51.21M69.33M166.79M69.33M156.12M138.44M213.22M216.50M242.67M232.85M284.06M
Interest Expense % of Total Revenue0.69%2.09%2.99%3.07%3.02%4.87%5.59%4.66%3.50%3.72%7.63%2.77%5.60%4.51%7.18%9.90%10.55%12.53%17.81%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets553.43M551.47M698.31M1.85B1.92B2.95B3.47B3.59B4.65B7.99B9.44B8.63B8.46B9.78B11.38B9.35B8.28B7.50B6.75B
Total Liabilities361.98M354.94M360.69M476.01M502.16M1.41B1.76B1.72B1.11B4.30B5.56B4.61B4.35B5.53B7.62B6.53B5.97B6.06B6.70B
Total Equity178.94M182.10M320.54M1.35B1.39B1.48B1.61B1.74B3.41B3.40B3.46B3.43B3.49B3.62B2.95B2.41B1.92B1.05B-360.32M
Cash44.47M40.07M89.08M1.15B785.99M1.29B761.21M334.41M657.33M835.79M1.41B650.11M495.69M605.14M196.12M166.50M149.32M131.74M254.57M
Total Debt138.40M156.50M183.00M302.50M332.50M1.19B1.13B1.17B540.98M2.35B3.47B3.62B2.68B3.96B3.45B2.46B2.43B1.96B-
Net Debt93.93M116.43M93.92M-849.75M-453.49M-100.69M368.61M837.48M-116.36M1.51B2.06B2.97B2.19B3.36B3.25B2.29B2.28B1.82B1.07B

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow138.02M55.72M46.19M45.47M29.55M118.91M328.37M165.58M159.89M198.48M109.53M91.24M83.02M257.18M257.56M227.38M263.44M18.17M139.63M
Investing Cash Flow-93.04M-82.89M-52.86M-56.87M-368.08M-451.51M-578.31M-503.76M-612.70M-2.57B-873.28M219.64M848.18M-1.24B-112.80M379.26M-53.66M34.96M-
Financing Cash Flow-10.36M12.51M64.76M1.07B-24.73M837.01M-290.24M-111.17M788.27M2.22B1.16B-757.48M-1.03B1.12B-450.22M-652.77M-200.63M-67.95M-
Capital Expenditure144.73M137.71M52.86M56.87M230.69M418.12M318.55M243.85M276.95M1.97B777.87M495.46M661.09M707.42M562.74M367.27M56.03M35.24M21.51M
Free Cash Flow-6.71M-81.99M-6.67M-11.40M-201.13M-299.22M9.82M-78.27M-117.06M-1.77B-668.33M-404.23M-578.07M-450.24M-305.18M-139.89M207.41M-17.07M118.12M
Dividends Paid17.63M42.01M11.84M64.70M54.73M79.98M147.70M150.27M135.20M157.26M172.23M207.38M21.28M31.34M216.91M175.80M140.65M50.55M5.84M
FCF to OCF-4.87%-147.14%-14.44%-25.08%-680.58%-251.64%2.99%-47.27%-73.21%-890.55%-610.16%-443.04%-696.31%-175.07%-118.49%-61.52%78.73%-93.90%84.59%
Dividend Paid to FCF-262.59%-51.23%-177.58%-567.50%-27.21%-26.73%1504.35%-191.98%-115.49%-8.90%-25.77%-51.30%-3.68%-6.96%-71.08%-125.67%67.81%-296.18%4.94%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Feb 26, 2014May 28, 2014Aug 26, 2014Oct 24, 2014Feb 25, 2015Apr 22, 2015Aug 24, 2015Oct 26, 2015Feb 27, 2016Apr 25, 2016Aug 24, 2016Oct 27, 2016Feb 26, 2017Apr 26, 2017Aug 25, 2017Oct 20, 2017Apr 27, 2018Aug 30, 2018Oct 29, 2018Apr 29, 2019Aug 29, 2019Oct 29, 2019May 19, 2020Aug 28, 2020Oct 24, 2020Apr 29, 2021Aug 28, 2021Oct 28, 2021Apr 29, 2022Aug 30, 2022Oct 28, 2022Apr 28, 2023Aug 29, 2023Dec 29, 2023Jun 7, 2024Aug 29, 2024Oct 26, 2024Apr 30, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------0.150.17-0.160.18-----0.180.180.180.18---------------------------
EPS Actual0.020.030.050.040.020.050.060.040.030.060.080.080.060.110.100.070.070.100.080.050.050.030.040.100.100.100.100.040.040.06-0.050.040.06-0.020.090.01-0.080.04-0.05-0.08-0.18-0.190.01-0.11-0.12-0.05-0.15-0.13-0.97-0.22-0.19-1.56-0.17-0.24
Surprise--------------26.67%-41.18%--56.25%-44.44%------44.44%-44.44%-44.44%-44.44%---------------------------
Timing-------------After-hoursPre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-market----------Pre-marketPre-market--------

Key Statistics & Ratios

Market Cap3.90B
Enterprise Value5.45B
Trailing P/E0.00
Forward P/E59.88
PEG Ratio0.00
Price / Sales2.64
Price / Book9.57
EPS-2.17
Book Value-0.959
Revenue (TTM)1.48B
Gross Profit (TTM)434.65M
EBITDA136.95M
Profit Margin-96.42%
Operating Margin-4.24%
Return on Equity-285.54%
Return on Assets-0.35%
Shares Outstanding661.28M
Shares Float479.12M
Beta0.54
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
0.05Jun 23, 2020
20191×
0.03Aug 9, 2019
20181×
0.03Jun 21, 2018
20161×
0.12Jun 3, 2016
20151×
0.11May 22, 2015
20141×
0.10Jul 14, 2014
20131×
0.10Jun 17, 2013
20121×
0.08Apr 27, 2012
20111×
0.06May 23, 2011

Stock Splits

  • Jul 14, 201413:10
  • Jun 17, 201313:10
  • Apr 27, 201212:10
  • May 23, 201120:10